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Background: Prostate cancer is a common and often deadly cancer. Decades of study
have yet to identify genes that explain much familial prostate cancer. Traditional linkage
analysis of pedigrees has yielded results that are rarely validated. We hypothesize that
there are rare segregating variants responsible for high-risk prostate cancer pedigrees,
but recognize that within-pedigree heterogeneity is responsible for significant noise that
overwhelms signal. Here we introduce a method to identify homogeneous subsets of
prostate cancer, based on cancer characteristics, which show the best evidence for an
inherited contribution.
Methods: We have modified an existing method, the Genealogical Index of Familiality
(GIF) used to show evidence for significant familial clustering. The modification allows a
test for excess familial clustering of a subset of prostate cancer cases when compared to
all prostate cancer cases.
Results: Consideration of the familial clustering of eight clinical subsets of prostate cancer
cases compared to the expected familial clustering of all prostate cancer cases identified
three subsets of prostate cancer cases with evidence for familial clustering significantly in
excess of expected. These subsets include prostate cancer cases diagnosed before age
50 years, prostate cancer cases with body mass index (BMI) greater than or equal to 30,
and prostate cancer cases for whom prostate cancer contributed to death.
Conclusions: This analysis identified several subsets of prostate cancer cases that cluster
significantly more than expected when compared to all prostate cancer familial clustering.
A focus on high-risk prostate cancer cases or pedigrees with these characteristics will
reduce noise and could allow identification of the rare predisposition genes or variants
responsible.
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INTRODUCTION
Prostate cancer is the most commonly diagnosed cancer in men
and is the second leading cause of cancer deaths among men
(ACS, 2013). While there is significant evidence of a genetic con-
tribution (Cannon et al., 1982; Carter et al., 1993; Stanford and
Ostrander, 2001; Langeberg et al., 2007), decades of investiga-
tion into the genetic causes of familial prostate cancer has yet
to clearly identify genes or variants which explain much more
than a small number of pedigrees with an excess of prostate can-
cer. Traditional linkage analysis of thousands of high-risk prostate
cancer pedigrees has elucidated little in the identification of pre-
disposition genes responsible for prostate cancer pedigrees. This
may reflect the heterogeneous nature of prostate cancer, and
this could confound identification of informative homogeneous
pedigrees segregating rare predisposition variants.
We hypothesize that there exist rare prostate cancer predispo-
sition variants that are responsible for our observation of high
risk prostate cancer pedigrees including homogeneous prostate
cancer cases (defined by clinical characteristics). We present a
methodology to compare subsets of prostate cancer cases and
identify those that show more familial clustering than expected
for all prostate cancer cases.
Using a population-based resource in Utah that combines
genealogy and cancer data, we identified 3 subsets of prostate can-
cer cases that cluster in pedigrees more than expected: prostate
cancer which is diagnosed before age 50 years, lethal prostate can-
cer (leading to metastasis and death from prostate cancer), and
prostate cancer in men with BMI ≥ 30. We propose that analysis
of the high-risk prostate cancer cases or pedigrees with an excess
of prostate cancer cases with these characteristics could lead to
identification of the rare predisposition variants responsible.
DATA ANDMETHODS
The Utah Population Data Base (UPDB) integrates three key elec-
tronic datasets: a Genealogy of the Utah pioneers constructed
in the 1970s and kept current (Skolnick, 1980), death certifi-
cates for Utah, and a statewide cancer registry. The original Utah
genealogy had approximately 1.6 million individual records for
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186,000 three-generation families. Since the genealogy was cre-
ated in the 1970s, state vital records have been used to create
genealogy triplets (mother, father, and child) to extend the geneal-
ogy to present day. The UPDB has become a person-oriented
database with information on 7 million Utahns, some 2.5 mil-
lion of whom have at least three generations of genealogy. The
Utah Cancer Registry (UCR) was created in 1966 to collect data
on all cancer diagnosed in Utah. It became a SEER (Surveillance,
Epidemiology, and End-Results) Registry of the National Cancer
Institute in 1973. The UCR individual records are linked to
the Utah genealogy annually; approximately 2/3 of UCR cases
link to a record in the UPDB. Cause of death from Utah state
death certificates from 1904 to present have been coded to ICD
Revisions 6–10, and record linked to the UPDB. Utah Drivers
License records from 1970 have been linked to the UPDB and
include height and weight measurements for calculation of body
mass index (BMI). The combination of genealogy, death certifi-
cates, drivers license data, and cancer registry data facilitates the
identification of all Utah prostate cancer cases and the genetic
relationships between them.
To perform the genetic analyses presented here we restrict our-
selves to those individuals in the UPDB with ancestral genealogy
data. We identified all individuals in the UPDB who were born
before 1972 (when the original Utah genealogy was constructed)
and whose parents, four grandparents, and six (of eight total)
great grandparents are present in the UPDB genealogy data. This
identifies 1.2 million individuals with ancestral genealogy data
who are used for all analyses.
We have extended a well-published analysis method, the
Genealogical Index of Familiality (GIF), to enable comparison of
the relatedness of a subset of prostate cancer cases to the related-
ness of all prostate cancer cases. Those subsets with evidence for
significantly more relatedness than all prostate cancer cases are
hypothesized to represent homogeneous genetic subsets that will
be most informative for gene identification studies.
GENEALOGICAL INDEX OF FAMILIALITY (GIF) METHOD
For decades the GIF statistic has been used to quantify famil-
ial clustering of cancer and other phenotypes in the UPDB. This
well-established statistical method has yielded strong evidence of
heritability for several cancer phenotypes (Cannon et al., 1982;
Cannon-Albright et al., 1994; Larson et al., 2006; Albright et al.,
2012). The GIF was developed to test the hypothesis of excess
relatedness of individuals with a common phenotype. Excess
relatedness is measured by comparing the average relatedness
between all pairs of cases of interest to the expected relatedness
of matched controls from the Utah population. Since record link-
age of any subset of UPDB records may indicate better or different
quality data, for individuals with a death certificate, we select con-
trols from all UPDB individuals who have a Utah death certificate.
Since the UCR is statewide, we select controls for cancer cases
from the entire UPDB resource.
The relatedness of a pair of individuals in a set is measured
using the Malécot coefficient of kinship. The Malécot coefficient
of kinship mathematically expresses Mendelian inheritance pat-
tern probabilities that randomly selected homologous chromo-
somes are identical due to inheritance from a common ancestor.
For example, the Malécot coefficient for siblings is 1/4, avunculars
is 1/8, and first cousins 1/16. The GIF analysis tests excess related-
ness by comparing all pairwise relationships within a set of cases
to the expected relatedness measured in all pairwise relation-
ships in 1000 sets of matched controls randomly selected from
the UPDB. Controls were matched on characteristics that might
be associated with record linking and disease rates, including
five-year birth year cohort, sex, and birth state (Utah or not).
The overall GIF analysis tests for significant excess relatedness
(over what is expected in the UPDB population) among a group
of individuals. It can be performed on all prostate cancer cases,
and on subsets of cases based on cancer characteristics. It cannot,
however, determine which, if any, of these subsets exhibits the best
evidence for a genetic predisposition, and which therefore might
be the best set of high-risk pedigrees in which to search for genes.
NEW SUBSETGif TEST
Here we consider a modified GIF test and test the relatedness of
multiple subsets of prostate cancer cases to identify those which
exhibit excess relatedness above the observed relatedness among
all Utah prostate cancer cases. This modified GIF test is referred
to as the SubsetGif. Evidence for significant excess relatedness
for a subset of prostate cancer cases above the expected for all
prostate cancer cases could indicate the presence of a common
genetic cause shared by the homogeneous subset. The identifi-
cation and subsequent study of pedigrees including cases of such
a homogeneous subset might facilitate the identification of rare
predisposition genes.
CONTRIBUTION TO THE GIF BY GENETIC DISTANCE
It is possible to view the distribution of the contribution to the
GIF statistic by the pairwise genetic distance of the different rela-
tionships observed in cases (and controls). The genetic distance
represents the number of paths between a pair of individuals.
Genetic distance 1 represents parent/offspring pairs, genetic dis-
tance 2 represents siblings or grandparent/grandchild, genetic
distance 3 represents avunculars, and so forth.
RESULTS
In the UPDB resource, 18,291 prostate cancer cases were iden-
tified who also had ancestral genealogical records. The available
prostate cancer subsets and their corresponding sample sizes are
outlined in Table 1.
Table 1 | Subsets of prostate cancer and sample size.
Set of prostate cancer cases n
All prostate cancers 18,291
Age at diagnosis <50 years 213
Metastatic disease at diagnosis 912
With at least 1 primary cancer of other site 2922
Gleason score >7 at diagnosis 4784
Short survival (0–9 months) 1180
Long survival (240 + months) 806
High BMI (≥30) 2459
Prostate cancer cause of death (lethal prostate cancer) 3982
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ANALYSIS OF EXCESS RELATEDNESS
Previous studies have strongly supported evidence for a genetic
contribution to predisposition to prostate cancer in the Utah
population, as well as other populations (Cannon et al., 1982;
Cannon-Albright et al., 1994, 2005). When all prostate cancer
cases with genealogy data in the UPDB are analyzed there is evi-
dence of excess relatedness (represented by both close and distant
genetic relationships) over expected relatedness in matched Utah
population controls. Table 2 shows the traditional GIF test for
excess relatedness compared to matched Utah population con-
trols for all prostate cancer cases, and for each subset. The mean
relatedness for cases and controls is shown. All prostate can-
cer cases and subsets, except prostate cases who survived less
than 10 months after diagnosis, show strong evidence for excess
clustering compared to Utah population controls. These results
suggest a genetic contribution to prostate cancer predisposition,
and suggest that study of almost all subsets of prostate cancer
could be fruitful, but the results do not allow identification of
which, if any, of the subsets are significantly more related than
expected when compared to all prostate cancer cases, and thus
show the best evidence for a genetic contribution.
In order to consider the hypothesis that a subset of prostate
cancer cases represents a more homogeneous subset of highly
related cases, we propose use of the SubsetGif analysis. The
average pairwise relatedness of each subset of cases is compared
to the average pairwise relatedness of 1000 sets of matched “con-
trols”; these controls are selected from the set of 18,291 Utah
prostate cancer cases. The results for this SubsetGif test are shown
in Table 3. The average pairwise relatedness of the cases does
not change for any subset (as expected), but the mean control
GIF statistic is higher than in Table 2 for each subset because
the “controls” here are randomly selected prostate cancer cases,
who are more closely related than random members of the Utah
population.
Table 3 results show that the average pairwise relatedness of
three different subsets of prostate cancer cases is significantly
higher than expected among prostate cancer cases, supporting
the hypothesis that these subsets of cases cluster more than all
prostate cancer cases and represent sets on which to focus for pre-
disposition gene identification. The three subsets include prostate
cancer cases diagnosed before age 50 years, prostate cancer cases
with BMI ≥ 30, and prostate cancer cases whose cause of death is
prostate cancer (lethal prostate cancer).
It is difficult to determine whether these three subsets repre-
sent independent groups of interest or whether there is overlap
between the groups because not all cases have BMI and death cer-
tificate data. There were 222 prostate cancer cases with BMI ≥
30 among the 3982 cases with prostate cancer as a cause of death
(6% total and 17% of the 1300 lethal cases with BMI data), and
58 prostate cancer cases with BMI ≥ 30 of the 213 cases who were
Table 2 | GIF analysis of prostate cancer relatedness compared to expected relatedness in the UPDB population.
Group n Case GIF Mean control GIF Empirical significance
All prostate cancers 18,291 5.54 4.74 <0.001
Age at diagnosis <50 years 213 11.72 4.54 <0.001
Metastatic disease at diagnosis 912 5.94 4.89 <0.001
With at least 1 primary cancer of other site 2922 5.58 4.74 <0.001
Gleason score >7 at diagnosis 4784 5.41 4.69 <0.001
Short survival (0–9 months) 1180 5.19 4.92 0.138
Long survival (240 + months) 806 5.64 4.75 0.005
BMI ≥ 30 2459 5.81 4.71 <0.001
Prostate cancer cause of death* (lethal) 3982 5.98 4.93 <0.001
*Because the subset of lethal prostate cancer cases differs from all prostate cancer cases with respect to the identification of a linked death certificate record, and
because the fact of record linking may suggest different data quality, we performed the GIF analysis for the subset of cases with prostate cancer contributing to
death in Tables 2, 3 using only the 10,421 prostate cancer cases with a linked Utah death certificate as controls; this is the standard for analysis of sets of individuals
selected from Utah death certificate data (Cannon-Albright, 2008).
Table 3 | Subset prostate cancer relatedness compared to expected prostate cancer case relatedness in the UPDB.
Prostate cancer subsets n Case GIF Mean control GIF Empirical significance
Age at diagnosis <50 years 213 11.72 7.51 0.024
Metastatic disease at diagnosis 912 5.94 5.95 0.506
With at least 1 primary cancer of other site 2922 5.58 5.51 0.303
Gleason Score >7 at diagnosis 4784 5.41 5.39 0.417
Short Survival (0–9 months) 1180 5.19 6.08 1.000
Long Survival (240 + months) 806 5.64 5.56 0.400
BMI ≥ 30 2459 5.81 5.27 <0.001
Prostate cancer cause of death (lethal) 3982 5.98 5.76 0.030
Controls randomly selected from 18,291 prostate cancer cases.
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diagnosed before age 50 years (27%). Overall, 11,536 prostate
cancer cases had BMI data, and 21.3%were BMI≥ 30. There were
26 prostate cancer cases diagnosed before age 50 years (0.7%)
among the 3982 lethal prostate cancer cases, and overall the 213
prostate cancer cases diagnosed before age 50 years represented
1% of all cases.
In order to determine the overall distribution of excess relat-
edness we can view the contribution to the GIF statistic by the
pairwise genetic distance for cases and for controls. Figure 1
shows the GIF distribution for all 18,291 prostate cancer cases
compared to the distribution for the 1000 sets of matched Utah
population controls. The comparison shows that the relatedness
for prostate cancer cases exceeds that expected in the Utah popu-
lation, as observed in randommatched Utah controls, for genetic
distances up to 7 (e.g., second cousins once removed).
Figures 2–4 show the contribution to the GIF statistic for the
three subsets of cases, with matched controls randomly selected
from all Utah prostate cancer cases. Figure 2 shows this distribu-
tion for prostate cancer cases with BMI ≥ 30; as seen in Table 3
there is significant excess relatedness for prostate cases with
BMI ≥ 30. This excess extends to a genetic distance of 5, equiv-
alent to first cousins once removed, for example. Figure 3 shows
this distribution for prostate cancer cases diagnosed before age
50 years, which is also observed to show significant excess relat-
edness. The excess relatedness is irregular, but is clearly observed
for genetic distance = 2 (siblings primarily), and distance = 8
(third cousins, for example). Figure 4 shows the GIF distribution
for lethal prostate cancer cases, also observed to show significant
excess clustering when compared to all deceased prostate cancer
cases. The excess extends to genetic distance = 4, equivalent to
first cousins, for example.
Figures 5–7 show examples Utah high-risk prostate cancer
pedigrees for each of the subset characteristics identified.
DISCUSSION
Analysis of a population-based Utah resource linking cancer
characteristics data with genealogy data has previously shown evi-
dence for a genetic contribution to prostate cancer predisposition
FIGURE 1 | Contribution to the GIF statistic by pairwise genetic
distance for cases and controls for all prostate cancers vs. population.
(Cannon et al., 1982; Cannon-Albright et al., 1994, 2005; Albright
et al., 2012; Teerlink et al., 2012). Here we have extended a well-
published analysis method which tests for excess relatedness in a
set of individuals to allow the identification of subsets of prostate
cancer cases who show the strongest evidence for excess familial
clustering. The subsets identified might be argued to represent the
most informative sets of cases or pedigrees to be studied for rare
predisposition gene identification.
Some of the subsets of prostate cancer cases that show sig-
nificant evidence of clustering in excess of expected for prostate
cancer were expected, some represent new subsets of interest
for genetic studies. The subset of men diagnosed with prostate
cancer before age 50 years is not surprising; there is much liter-
ature suggesting a strong genetic contribution to cancer of most
sites that is diagnosed early (Goldgar et al., 1994; Brandt et al.,
2008) and much analysis of this subset of prostate cancer cases
and pedigrees has been performed (Gronberg et al., 1999; Xu
et al., 2005). However, the other two groups of prostate cancer
FIGURE 2 | Contribution to the GIF statistic by pairwise genetic
distance for cases and controls for prostate cancer cases with a BMI of
30 or greater.
FIGURE 3 | Contribution to the GIF statistic by pairwise genetic
distance for cases and controls for prostate cancer cases diagnosed
before age 50.
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FIGURE 4 | Contribution to the GIF statistic by pairwise genetic
distance for cases and controls for prostate cancer cases that have
prostate cancer as a cause of death.
FIGURE 5 | High risk Utah prostate cancer pedigree (56 prostate cancer
cases observed among descendants of the pedigree founder, 36
expected, p = 0.001); cases with BMI ≥ 30 are shown.
FIGURE 6 | High risk Utah prostate cancer pedigree (173 prostate
cancers observed among descendants of the pedigree founder, 131
expected, p = 0.0003); cases diagnosed before age 50 years are
shown. The two cases with an asterisk were also observed to have
BMI ≥ 30 (data not available for all cases).
cases identified, high BMI (≥30) and lethal prostate cancer cases,
have not been suggested previously as associated with a strong
genetic contribution for prostate cancer. There was some overlap
of prostate cancer cases between these sets; further investigation
of specific high-risk pedigrees will determine whether they are
independent.
Although epidemiologic studies have shown that systemic
metabolic disorders including obesity might increase risk for
prostate cancer, BMI in the context of high risk prostate cancer
FIGURE 7 | High risk Utah prostate cancer pedigree (76 prostate cancer
cases observed among descendants of the pedigree founder, 51.5
expected, p = 0.0008); cases known to have died from prostate cancer
are shown.
pedigrees does not appear to have been studied. Since there is evi-
dence for familial clustering of high BMI or obesity (independent
of cancer status), it is possible that these results are due, at least
in part, to a shared predisposition to obesity. Nevertheless, these
results suggest this is an informative set of pedigrees to be studied
for prostate cancer risk.
The familiality of aggressive prostate cancer has been noted,
and subsets of aggressive prostate cancer cases have been stud-
ied, without any gene identifications (Paiss et al., 2003; Lange
et al., 2006; Schaid et al., 2006; Christensen et al., 2007). Little
progress has been made in understanding why 30% of all patients
with localized prostate cancer eventually develop recurrent, and
subsequently fatal, prostate cancer. Rather than subset aggres-
sive prostate cancers, we specifically targeted the pathogenesis of
lethal prostate cancer. This subtle definition difference focuses
on the subtype of prostate cancer which is associated with the
worst prognosis i.e., which kills, but our definition ignores age
at onset and pathology grading data for the individual, both of
which are more commonly used to classify prostate cancer cases
for aggressive status, but which can be poor markers for survival.
This subset of lethal prostate cancer cases, among all others, is
the most clinically significant and that which could yield the most
translational opportunities were genes to be identified.
The Utah population has proven valuable to the study of many
common cancers, and to the isolation of multiple cancer predis-
position genes. The University of Utah group has been studying
high-risk cancer pedigrees since 1972, and has built a resource
of thousands of extended high-risk pedigrees that includes over
35,000 DNA samples. The study of extended pedigrees allowed
our research group to isolate BRCA1 (Miki et al., 1994), to local-
ize and isolate BRCA2 (Wooster et al., 1994; Tavtigian et al.,
1996), to localize and isolate p16 (Cannon-Albright et al., 1992,
1994; Kamb et al., 1994), and to localize and isolateHPC2/ELAC2
(Tavtigian et al., 2001). These findings of excess relatedness in the
UPDB for three subsets of prostate cancer cases represent multiple
Utah high-risk prostate cancer pedigrees for each of the subsets.
Analysis of these high risk pedigrees will lead to identification of
the predisposition genes responsible, which might otherwise not
be identifiable in studies of all high-risk prostate cancer pedigrees
combined.
We have identified significant evidence for three charac-
teristics of prostate cancer that independently coaggregate in
both close and distant relatives. We have identified multiple
high-risk prostate cancer pedigrees that independently include
multiple prostate cancer cases with the characteristics of interest.
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Figures 5–7 show an example Utah high-risk prostate cancer
pedigree for each of the three characteristics identified. We pro-
pose that linkage analysis or shared genomic segment (Thomas
et al., 2008) analysis can identify chromosomal regions shared
in the related cases and that sequence analysis of predisposition
carriers in the targeted regions located will lead to identification
of the responsible predisposition genes. Rather than studying all
high-risk prostate cancer pedigrees, we instead will focus on those
that exhibit multiple cases with those characteristics most likely
to have a genetic contribution. These studies will examine fewer
pedigrees than a typical prostate cancer pedigree study, but will
focus on the homogeneous subsets most likely to represent rare
segregating predisposition genes or variants.
These findings should be generalizable to the U.S.A. popula-
tion. Utah was originally settled by ∼10,000 Mormons of British,
Scandinavian, and German origin. They, and the more than
50,000 migrants from the same areas who arrived in the next
generations, have typical Northern European gene frequencies
(McLellan et al., 1984) and low to normal levels of inbreed-
ing compared to the U.S. (Jorde, 1989). These characteristics
make this population appropriate for inferences in populations
of Northern European descent. The predisposition genes identi-
fied in Utah are represented similarly in other studies in terms
of frequency, penetrance, and interactions with risk factors and
modifier genes. Utah cancer rates are lower than U.S. rates, most
likely due to lower rates of smoking and alcohol use.
Recent advances in mapping the genome, combined with the
unique resources of Utah, provide a rare opportunity for a suc-
cessful search for predisposition genes or variants for prostate
cancer and the definition of their role at a population level. Recent
evidence has shown the advisability and efficiency of rare pre-
disposition gene identification by study of extended pedigrees
(Ewing et al., 2012; Roberts et al., 2012). Here we identify char-
acteristics of prostate cancer that can be used to more specifically
focus gene identification efforts on appropriate pedigrees. The
eventual identification of predisposition genes for prostate cancer,
accompanied by a greater understanding of how these genes con-
tribute to morbidity and mortality, will lead to the development
of diagnostic tests and more personalized treatments for prostate
cancer.
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